Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

SML3500

Sigma-Aldrich

Colesevelam hydrochloride

≥98% (HPLC)

Synonym(s):

1-Hexanaminium, N,N,N-trimethyl-6-(2-propenylamino)-, chloride, polymer with (chloromethyl)oxirane, 2-propen-1-amine and N-2-propenyl-1-decanamine, hydrochloride, 2-Propen-1-amine, polymer with (chloromethyl)oxirane, N-2-propenyl-1-decanamine and N,N,N-trimethyl-6-(2-propenylamino)-1-hexanaminium chloride, hydrochloride, CholestaGel, Colesevelam HCl, GT 31-104

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
(C13H27N.C12H27N2.C3H7N.C3H5ClO.Cl)x.xHCl
CAS Number:
UNSPSC Code:
12352200
NACRES:
NA.21

Quality Level

Assay

≥98% (HPLC)

form

powder

mol wt

581.79 g/mol

storage condition

desiccated

color

white to beige

storage temp.

-10 to -25°C

SMILES string

C=CCNCCCCCCCCCC.C=CCNCCCCCC[N+](C)(C)C.NCC=C.ClCC1OC1.[xHCl].[Cl-]

Biochem/physiol Actions

Colesevelam hydrochloride, a polyamine polymer, is an oral, non-absorbed bile acid sequestrant. Colesevelam hydrochloride absorbs bile acids in the intestine, which increases demand for cholesterol synthesis and affectively lowers low-density lipoprotein cholesterol (LDL-C) blood levels.

Caution

Hygroscopic

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sanjay Kalra et al.
JPMA. The Journal of the Pakistan Medical Association, 70(5), 934-936 (2020-05-14)
Colesevelam is a bile acid sequestrant, approved for the management of both dyslipidaemia and type 2 diabetes. This review discusses the potential for the use of colesevelam in the management of type 2 diabetes. Expert opinion suggests possible indications where
Phillipp Hartmann et al.
Hepatology international, 16(2), 359-370 (2022-01-26)
Obesity, non-alcoholic fatty liver disease (NAFLD) and its more advanced form non-alcoholic steatohepatitis (NASH) are important causes of morbidity and mortality worldwide. Bile acid dysregulation is a pivotal part in their pathogenesis. The aim of this study was to evaluate
Noemí Cabré et al.
Cells, 10(6) (2021-07-03)
Alcohol-related liver disease is associated with intestinal dysbiosis. Functional changes in the microbiota affect bile acid metabolism and result in elevated serum bile acids in patients with alcohol-related liver disease. The aim of this study was to identify the potential

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service